A-listers provide a $50M B round to AstraZeneca’s antibiotics spinout Entasis

John Carroll Last summer, AstraZeneca formally spun out its pared-down early-stage antibiotics unit in Waltham, MA, as Entasis Therapeutics, bequeathing a $ 40 million A round for ...

Scripps cancer spinout Xcovery grabs $20M from a pharma partner in China

John Carroll Chris Liang had already forged a compelling profile in drug development when the newly formed Scripps Florida recruited him as head of chemistry back in 2004. Liang, who ...

Aventis spinout Scynexis plots a $55M IPO to push an ex-Merck antibiotic

Damian Garde Durham, NC's Scynexis is queuing up for a $ 55 million IPO, looking to ride the wave of biotech bullishness and raise cash for its in-development anti-infective. FierceBiotech ...

UPDATED: Yale biotech spinout launches with $18M and a new approach to cancer

John Carroll Canaan Partners and 5AM Ventures are launching a new Yale spinout focused on a new approach to shutting down proteins. FierceBiotech News

Scripps spinout aTyr grabs $59M in venture deals with a public twist

Ryan McBride aTyr Pharma has raised $ 49 million in a Series D financing that included money from "one of the largest public funds in the world," Executive Chairman and CEO ...

Elan orchestrates $693M biotech buyout, $90M spinout in deal frenzy

John Carroll In a dealmaking frenzy, cash-rich Elan has agreed to pay up to $ 693 million for a biotech company focused on rare diseases, picked up a big share of a start-up specialty ...

Astellas, VCs stake virtual biotech spinout with $15M and a PhII program

John Carroll Astellas and a pair of venture companies have joined forces to launch a spinout virtual biotech which will pick up mid-stage research work on an experimental therapy for ...

Merck buddies up to Scripps spinout Abide in $430M diabetes partnership

John Carroll Yesterday Merck's top executives spent a considerable amount of time trying to reassure analysts that the Big Pharma company is actively engaged in the hunt for new ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS